A presentation last week at the 9th Annual Canadian Neuroscience Meeting brings some clarity (or complexity, depending on whether you’re a glass-half-full or glass-half-empty kind of critter) to the Good, the Bad, and the Completely Confusing topic of menopause-related hormone replacement therapy (HT). We say “completely confusing” because folks with ovaries have been subjected to…